Connect with us

INTERNACIONAL

EXCLUSIVE: Biden ATF promoted agents involved in ‘illegal’ scheme to inflate salaries, GOP senators say

Published

on


Two Senate Republicans are calling for immediate corrective action at the Bureau of Alcohol Tobacco, Firearms and Explosives (ATF), accusing agency officials of substantial misconduct, mismanagement, abuse of power and potential criminal misconduct after supervisory staff allegedly disregarded federal directives and standards in order to inflate their salaries. 

What’s more, instead of being disciplined, the supervisory agents who allegedly turned a blind eye to the misconduct – and in some cases allegedly retaliated against whistleblowers trying to expose it – were promoted under the Biden administration, the senators say.

Advertisement

«As a result of ATF’s illegal conduct, ATF staff assigned to these positions performed administrative work but unlawfully received enhanced law enforcement pay and benefits to which they were not entitled, wasting millions of taxpayer dollars,» Iowa’s Republican senators, Judiciary Chairman Chuck Grassley and Joni Ernst, wrote in a letter transmitted Friday to U.S. Attorney General Pam Bondi and ATF acting Director Daniel Driscoll. 

ARMY SECRETARY DAN DRISCOLL TO LEAD ATF, REPLACING FBI DIRECTOR KASH PATEL

In their letter, the senators cited two internal investigations from the Office of Personnel Management (OPM), which concluded in 2020 and ultimately suspended the ATF’s classification authority, and the ATF Internal Affairs Division (IAD), which was completed in early 2024. Despite the suspension from OPM in 2020, which was lifted in 2023, ATF officials disregarded OPM directives and continued to re-classify agency employees improperly, according to the senators.

Advertisement

Sens. Chuck Grassley and Joni Ernst are calling for immediate corrective action at the ATF, accusing supervisory agents there of turning a blind eye to a criminal scheme to inflate their salaries and, in turn, getting rewarded for it by the Biden administration. (Getty Images/Fox News)

In their letter, Grassley and Ernst singled out two supervisory agents, Lisa Boykin and Ralph Bittelari, who they say the IAD audit shows not only allowed the continuance of this misclassification scheme – despite knowing it violated OPM directives and standards – but also retaliated against whistleblowers trying to expose it. 

Furthermore, the senators claim, Boykin and Bittelari were promoted before President Joe Biden left office and continue to work at the ATF under President Donald Trump.

Advertisement

In one instance, according to the senators, Bittelari and Boykin decided to move forward with the relocation of an ATF law enforcement officer in Phoenix to an administrative position at ATF headquarters in Washington, D.C., despite OPM identifying the position as misclassified. The IAD report allegedly shows Bittelari initially agreed to rescind the job offer, but following a subsequent conversation with Boykin decided to move forward with the unauthorized relocation anyway.

SENATOR WARNS OF ‘UNCONSTITUTIONAL’ JUDICIAL OVERREACH AHEAD OF SCOTUS SHOWDOWN

Furthermore, the senators alleged in their letter that the IAD report shows Bittelari attempted to hide the «unlawful assignment» by submitting the promotion directly to payroll for processing.

Advertisement

During another instance when Bittelari sought to improperly classify a position description for the chief of ATF’s Workforce Wellness and Services Division (WWSD) as law enforcement, the senators said a human resources classification specialist was threatened with insubordination after recusing herself from the matter and sending an email notifying staff it was a violation of OPM directives and standards. 

The senator’s letter also highlighted Boykin’s «troubling lack of candor» regarding the installation of the chief of WWSD. According to the senators, Boykin told IAD investigators she was unsure if the chief of WWSD had been installed prior to the position description ever being adequately approved. However, the senators said, Boykin’s emails showed the individual attended meetings and functions with Boykin as WWSD chief prior to receiving approval, and a draft position description was created jointly by the pair weeks before the official WWSD chief position description was approved.   

«The findings in the IAD report present clear evidence that corrective action must be taken for, at minimum, Ms. Boykin’s and Mr. Bittelari’s gross misconduct,» the senators wrote. «Yet, the Biden ATF and DOJ leadership not only failed to hold Boykin or Bittelari accountable for their gross misconduct, but legally protected whistleblower disclosures provided to our offices show these career DOJ bureaucrats were promoted after the conclusion of the IAD investigation that harshly criticized their actions.»

Advertisement

The senators point out in their letter that Boykin was promoted to chief diversity officer under Biden, but in January 2025 her title was switched to «Senior Executive.» Meanwhile, the senators also pointed out Bittelari was promoted to senior advisor at the Justice Department’s Justice Management Division (JMD), and later acting deputy director of human resources within JMD.

ATF ACCUSED OF ‘CIRCUMVENTING’ TRUMP ORDER TO PLACE DEI STAFF ON PAID LEAVE

«In closing, the findings in the IAD and OPM audit reports further substantiate the claims whistleblowers made to our offices that senior ATF bureaucrats, Ms. Boykin and Mr. Bittelari, engaged in gross and substantial waste, fraud, abuse, and misconduct at the expense of taxpayers in furtherance of ATF’s illegal misclassification scheme, retaliated against whistleblowers for exposing it, and then were promoted for it,» stated Grassley and Ernst’s letter to Bondi and Driscoll. 

Advertisement

«Their complete disregard for the law despite being ‘fully aware of the potential consequences’ show Boykin and Bittelari should not have leadership positions at the Justice Department or its components.»

ATF Agent seen from behind

The ATF has previously come under fire for «circumventing» a directive by President Donald Trump to curbing DEI efforts at federal agencies. (Scott Olson/Getty Images)

CLICK HERE TO GET THE FOX NEWS APP 

In addition to calling for corrective action, Grassley and Ernst requested that no later than May 23 the Justice Department submit a response on how it plans to address the issues laid out in the IAD report and their letter. 

Advertisement

The Justice Department declined to comment for this article, while the ATF did not respond to Fox News Digital’s inquiries.

Senate,Republicans,Chuck Grassley,Politics,Second Amendment,Iowa

Advertisement

INTERNACIONAL

Justice Department investigating University of California over alleged DEI-based hiring

Published

on


NEWYou can now listen to Fox News articles!

The Justice Department has announced it is investigating the University of California (UC) for alleged Title VII discrimination violations in its hiring practices.

Advertisement

The agency announced Thursday that its Civil Rights Division is looking into the university’s individual campuses regarding potential race- and sex-based discrimination in employment practices.

The university’s «UC 2030 Capacity Plan» directs its campuses to hire «diverse» faculty members to meet race- and sex-based employment quotas, the Justice Department said.

The Justice Department has launched a Title VII investigation into the University of California over alleged race- and sex-based discrimination in faculty hiring. (AP Photo/Ben Margot, File)

Advertisement

UNIVERSITY OF MICHIGAN, LAW JOURNAL SUED FOR ALLEGEDLY DISCRIMINATING AGAINST STRAIGHT WHITE MALES 

«These initiatives openly measure new hires by their race and sex, which potentially runs afoul of federal law,» the Justice Department said in a press release. 

«The Civil Rights Division’s Employment Litigation Section will investigate whether the University of California is engaged in a pattern or practice of discrimination based on race, sex, and other protected characteristics, pursuant to Title VII of the Civil Rights Act of 1964.»

Advertisement

Title VII prohibits an employer from discriminating against an individual on the basis of race, color, religion, sex, or national origin, Harmeet Dhillon, the assistant attorney general of the Justice Department’s Civil Rights Division, said.

«Public employers are bound by federal laws that prohibit racial and other employment discrimination,» Dhillon said. «Institutional directives that use race- and sex-based hiring practices expose employers to legal risk under federal law.»

The Justice Department’s Civil Rights Division wrote to the university on Thursday, informing it of the investigation. 

Advertisement

«Our investigation is based on information suggesting that the University of California may be engaged in certain employment practices that discriminate against employees, job applicants, and training program participants based on race and sex in violation of Title VII,» the letter reads. 

«Specifically, we have reason to believe the University of California’s ‘UC 2030 Capacity Plan’ precipitated unlawful action by the University of California and some or all its constituent campuses.»

woman sitting in classroom with laptop next to words "diversity equity inclusion"

In March, UC dropped diversity statements from its hiring practices amid President Donald Trump’s threats that schools could lose federal funding. (iStock)

TRUMP ADMINISTRATION TARGETS IVY LEAGUE SCHOOL, LAW JOURNAL FOR RACIAL DISCRIMINATION

Advertisement

UC said it will work in good faith with the Justice Department as it conducts its investigation.

«The University of California is committed to fair and lawful processes in all of our programs and activities, consistent with federal and state anti-discrimination laws,» a UC statement provided to Fox News Digital reads. «The University also aims to foster a campus environment where everyone is welcomed and supported.»

The university’s UC 2030 Capacity Plan lays out a goal of becoming a national model as a Hispanic-Serving Institution (HSI) and Minority-Serving Institution (MSI) system. The plan outlines a pipeline strategy to diversify faculty and researchers through expanded graduate enrollment and outreach to institutions that serve underrepresented students. The DOJ, however, claims these initiatives may violate Title VII by functioning as de facto employment quotas.

Advertisement

In March, UC dropped diversity statements from its hiring practices amid President Donald Trump’s threats that schools could lose federal funding. 

The university’s provost, Katherine S. Newman, sent out a letter to the system’s leaders informing them that diversity statements are no longer required for new applicants. Newman wrote that while some programs and departments have required them, the university has never had a policy of diversity statements and believes it could harm applicant evaluation.

University of California, Berkeley campus

University of California, Berkeley entrance sign on the corner of Oxford Street and Center Street. (iStock)

CLICK HERE TO GET THE FOX NEWS APP

Advertisement

«The requirement to submit a diversity statement may lead applicants to focus on an aspect of their candidacy that is outside their expertise or prior experience,» the letter obtained by Fox News Digital reads.

She added that employees and applicants can still reference accomplishments related to diversity, equity and inclusion (DEI) on their own, but requiring stand-alone diversity statements is no longer permitted. 

Fox News’ David Spunt and Lindsay Kornick contributed to this report

Advertisement

Continue Reading

INTERNACIONAL

Iranian foreign minister reiterates ‘serious damage’ to nuclear facilities, despite ayatollah’s comments

Published

on


NEWYou can now listen to Fox News articles!

Iranian Foreign Minister Abbas Araghchi admitted in an interview on state TV that the U.S.’s strikes caused serious damage to Tehran’s nuclear facilities, despite Ayatollah Ali Khamenei’s insistence that there was minimal impact.

Advertisement

Araghchi said in the interview that «the level of damage is high, and it’s serious damage,» according to the Associated Press.

Post-strike assessments have shown that Iran’s nuclear sites suffered damage in both U.S. and Israeli attacks. All three countries — Iran, Israel and the U.S. — have reached similar conclusions about the extent of the damage, despite what a leaked intel report indicated.

Iranian Foreign Minister Abbas Araghchi contradicts Ayatollah Ali Khamenei on the extent of damage caused by U.S. strikes on the country’s nuclear facilities. (Associated Press)

Advertisement

IRAN, ISRAEL AND US AGREE THAT ISLAMIC REPUBLIC NUCLEAR SITES WERE ‘BADLY DAMAGED’ DESPITE LEAKED INTEL REPORT

The only leader who seemingly does not agree with the assessments is Ayatollah Ali Khamenei, who said that «the Americans failed to achieve anything significant in their attack on nuclear facilities,» according to reports. 

Khamenei appears to be more focused on projecting strength than reflecting reality. He described Iran’s attack on Al-Udeid, the American airbase in Qatar, as a «heavy slap to the U.S.’s face.» While President Donald Trump dismissed it as a «very weak response» and thanked Iran for giving the U.S. «early notice.»

Advertisement

International Atomic Energy Agency (IAEA) Director General Rafael Grossi said in a statement on Tuesday that the agency had «seen extensive damage at several nuclear sites in Iran, including its uranium conversion and enrichment facilities.»

damage at the Fordow enrichment facility

This satellite picture by Planet Labs PBC shows Iran’s underground nuclear enrichment site at Fordo following U.S. airstrikes targeting the facility, on Sunday, June 22, 2025. (Planet Labs PBC via AP)

IRAN TRYING TO ‘SAVE FACE’ FOLLOWING US STRIKE ON NUCLEAR SITES, EXPERT SAYS

In addition to discussing the damage done to Iran’s nuclear sites, Araghchi also addressed the possibility of resuming talks with the U.S. He said that the American strikes «made it more complicated and more difficult» for Iran to come to the table, but did not rule out the possibility that negotiations could resume.

Advertisement

Nuclear talks with the U.S. might not be entirely off the table for Iran after last week’s strikes—even if Tehran is not interested in reentering negotiations right away.

The possibility of negotiations was already in question prior to Operation Midnight Hammer, as Tehran viewed the U.S. as being «complicit» in Israel’s Operation Rising Lion, according to Reuters, citing Iranian U.N. Ambassador Ali Bahreini.

President Trump Delivers Address

US Vice President JD Vance, from left, US President Donald Trump, Marco Rubio, US secretary of state, and Pete Hegseth, US secretary of defense, during an address to the nation in the East Room of the White House in Washington, DC, US, on Saturday, June 21, 2025.  (Carlos Barria/Reuters/Bloomberg via Getty Images)

EX-SECRETARY OF STATE CONDOLEEZZA RICE CALLS US STRIKES ON IRAN A ‘SHOT IN THE ARM’ FOR AMERICAN CREDIBILITY

Advertisement

Trump on Wednesday expressed optimism in the U.S.’s ability to resume nuclear talks with Iran.

«We’re going to talk to them next week, with Iran. We may sign an agreement, I don’t know. To me, I don’t think it’s that necessary. I mean, they had a war. They fought. Now they’re going back to their world. I don’t care if I have an agreement or not. The only thing we would be asking for is what we’re asking for before about, we want no nuclear [program]. But we destroyed the nuclear,» Trump said. 

Despite Trump’s statement, there is still no clear indication that the countries have plans to meet in the near future.

Advertisement

CLICK HERE TO GET THE FOX NEWS APP

The Associated Press contributed to this report.

Advertisement


Advertisement
Continue Reading

INTERNACIONAL

Terapia psicodélica aprobada en Nueva Zelanda. Él es el único médico que puede realizarla

Published

on


El Dr. Cameron Lacey lleva años estudiando cómo los psicodélicos podrían ayudar a tratar la depresión y otros trastornos del estado de ánimo.

La semana pasada, se convirtió en el primer y único psiquiatra de Nueva Zelanda autorizado para recetar psilocibina, el alucinógeno presente en los hongos alucinógenos.

Advertisement

La aprobación del Ministerio de Salud de Nueva Zelanda es el último impulso a un creciente movimiento global para estudiar y utilizar psicodélicos como la psilocibina y el MDMA, relegados durante mucho tiempo a los márgenes de la psiquiatría, para tratar la depresión, el trastorno de estrés postraumático y el abuso de sustancias.

Según el Ministerio de Salud, Lacey fue seleccionado por su amplia experiencia en el uso seguro de psilocibina para el tratamiento psiquiátrico durante ensayos clínicos.

Comentó que en 2021 comenzó a investigar un ensayo clínico con psilocibina tras observar que muchos de sus pacientes no respondían a los antidepresivos.

Advertisement

El gobierno ha declarado que los tratamientos con psilocibina estarán estrictamente controlados.

Un vendedor embolsa setas de psilocibina en un mercado emergente de cannabis en Los Ángeles. A pesar de las condiciones pandémicas que hicieron casi imposible la recogida normal de firmas, los activistas de la capital del país dicen tener suficientes firmas para una iniciativa electoral en noviembre que despenalizaría los psicodélicos naturales como la mescalina y las setas de psilocibina. (AP Photo/Richard Vogel, File)

Los pacientes no podrán simplemente irse de una cita con una tableta o mezcla que contenga psilocibina, que Nueva Zelanda aún clasifica como una droga ilegal, junto con la heroína y la cocaína.

En cambio, dijo Lacey, recibirán su primera dosis después de tres sesiones de terapia de conversación.

Advertisement

Luego, acostados o sentados en un sillón reclinable, con antifaces y auriculares con cancelación de ruido, los pacientes recibirán 25 miligramos de psilocibina en una cápsula.

La experiencia alucinógena, o viaje, comienza unos 45 minutos después, dijo, mientras se escuchan sonidos de la naturaleza y música tradicional maorí por los auriculares.

El viaje dura unas ocho horas.

Advertisement

“Las personas pueden experimentar todo un caleidoscopio de emociones, y eso puede ser bastante intenso, a veces bastante desafiante”, dijo Lacey en una entrevista telefónica.

Como con cualquier alucinógeno, añadió, los viajes pueden ser difíciles o perturbadores, y algunos pacientes se sienten nerviosos el día de la dosis porque esperan una experiencia intensa.

En casos raros, los pacientes pueden continuar experimentando alucinaciones después de terminar el viaje.

Advertisement

«Puede ser una experiencia angustiosa, ya que las personas continúan reviviendo algunas de las experiencias que tuvieron durante la dosis de psilocibina», dijo.

En las sesiones de terapia posteriores al viaje, los pacientes hablan sobre los sentimientos y recuerdos que experimentaron mientras tomaban psilocibina y que podrían ser la causa de su depresión, explicó Lacey.

Durante su ensayo clínico con psilocibina, dos tercios de los participantes mostraron una reducción de los síntomas de depresión, añadió.

Advertisement

El programa de tratamiento tiene una duración de 10 a 12 semanas, añadió Lacey.

La investigación de Lacey se inspiró en parte en los maoríes, el pueblo indígena de Nueva Zelanda, cuyo enfoque holístico de la salud ha sido otro de los ejes de su investigación.

Algunos pueblos indígenas, incluidos los maoríes, han utilizado ciertos hongos para fomentar una profunda introspección durante rituales y ceremonias tradicionales y para curar trastornos mentales, según investigadores de la psilocibina.

Advertisement

El trabajo de Lacey podría allanar el camino para una aprobación más amplia, que también podría permitir a las aseguradoras de salud considerar cubrir la terapia con psilocibina.

Legalización

En 2023, la vecina Australia legalizó el uso de psilocibina y MDMA, el estimulante más comúnmente conocido como éxtasis, para tratar la depresión y el trastorno de estrés postraumático.

Advertisement

En Estados Unidos, la psilocibina está clasificada como sustancia de la Lista I por el gobierno federal, una designación para drogas con alto potencial de abuso y sin usos médicos actualmente aceptados.

Sin embargo, se están realizando múltiples ensayos clínicos en EE.UU. para estudiar su potencial para tratar la adicción y la depresión.

La creciente popularidad de la psilocibina se debe en parte a ensayos clínicos exitosos como el de Lacey y a su menor potencial de adicción o sobredosis en comparación con otros alucinógenos como la ketamina.

Advertisement

Estudios también han demostrado que el efecto antidepresivo de la ketamina desaparece con el tiempo, lo que podría conducir al abuso.

Sin embargo, el tratamiento con psilocibina de Lacey no es económico.

El programa de 10 semanas puede costar entre 16.000 y 19.500 dólares.

Advertisement

A pesar del elevado precio, comentó, otros psiquiatras lo habían contactado para ofrecer el tratamiento a sus pacientes, quienes previamente habían considerado viajar a otros países para recibir terapia con psilocibina.

El sistema de salud de Nueva Zelanda cubre el tratamiento y los medicamentos de salud mental completamente aprobados.

Además, Lacey señaló: «Existe un alto costo personal por el deterioro y la discapacidad que han sufrido debido a experiencias de depresión y otras afecciones que no mejoran por completo».

Advertisement

c.2025 The New York Times Company

Continue Reading

LO MAS LEIDO

Tendencias

Copyright © 2025 NDM - Noticias del Momento | #Noticias #Chimentos #Política #Fútbol #Economía #Sociedad